Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) — Form 144: Proposed sale of shares
AI-generated summary
Officer and Director Bernard J Zovighian proposed to sell 46,200 common shares of Edwards Lifesciences Corporation with an aggregate market value of $4,759,559 through Charles Schwab & Co., Inc. The shares were acquired via an employee stock option exercise on November 9, 2026. The proposed sale is associated with a trading plan adopted on July 28, 2026.
Key facts
- Seller
- Zovighian Bernard J
- Relationship
- Officer, Director
- Shares to sell
- 46,200
- Market value
- $4,759,559.00
- Approximate sale date
- Nov 9, 2026
- Broker
- Charles Schwab & Co., Inc.
- Acquired
- Nov 9, 2026 · Employee Stock Option Exercise - See Remarks
Rule 10b5-1 plan · adopted Jul 28, 2026
Remarks
- The options on this filing may be sold over various dates.
More EW filings
- 4
Filed Nov 9, 2026
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 10-Q
Filed Nov 4, 2026
- 8-K
Filed Nov 4, 2026
- 4
Filed Oct 8, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.